Frequently Asked Questions

What is Belkyra®/Kybella®?

Belkyra ® (Known as KYBELLA ® in the United States) is an injectable fat dissolving treatment that reduces sub-mental (under the chin) fat. This new FDA procedure can eliminate a double chin without surgery and can improve definition of the jawline.
Belkyra ® is comprised of a synthetic form of deoxycholic acid, a naturally occurring substance in the human body. When injected into the treatment area it destroys the membranes of local fat cells, thereby releasing the fat inside. This fat is then naturally eliminated from the body.

What are the main uses of Belkyra®/Kybella®?

Belkyra ® is licenced for dissolving sub-mental fat and for improving jawline definition. It can also be used to dissolve abdominal fat including the love handles.

Do Belkyra®/Kybella® injections hurt?

Discomfort during the procedure is minimised by using a topical anaesthetic cream and if required, a local anaesthetic injection.

Who will perform the treatment and how much will it take?

Dr R Baba will perform the treatment and it will take approximately 15 minutes.

How long does it take Belkyra/Kybella to work?

Following the injection of Belkyra into the treatment area it takes between 2- 4 weeks for the fat cells to dissolve and for the effects of treatment to become visible.

How long is the downtime with Belkyra®/Kybella®?

Downtime following Belkyra injections is minimal. Most clients return to work and resume normal daily activity immediately after treatment. It is advised that strenuous exercise for a few days after treatment as this can increase bruising and exacerbate localised swelling.

What are the side effects of Belkyra®/Kybella®?

Side effects following Belkyra treatment are relatively minor and can be easily managed. The most common side effect is swelling near the injection site which can last for a few days following treatment. Other potential side effects may include; bruising, itchiness, redness, and mild discomfort. Very occasionally clients can experience some tenderness surrounding the injection site which for some individuals can persist up to two months post treatment.

Who is not suitable for Belkyra®/Kybella®?

Belkyra treatment is contraindicated in pregnant or breastfeeding women and clients who have severe liver or heart problems.